Adventitious Agent Risk Assessment Case Study: Evaluation of RotaTeq® for the Presence of Porcine Circovirus

References

1. 1.↵
   1. Willkommen H.,
   2. Scheiblauer H.,
   3. Lowrer J.

   Serum and serum substitutes: virus safety by inactivation or removal. Dev. Biol. Stand. 1999, 99, 131–138.

   OpenUrlPubMed
2. 2.↵
   1. Pavsic M. Z.,
   2. Bolin S.

   Resistance of bovine circovirus to gamma irradiation. BioPharm International 2001, 14 (4), 32–37.

   OpenUrl
3. 3.↵
   Guidance for Industry—Characterization and Qualification of Cell Substrates and Other Biological Materials Used in the Production of Viral Vaccines for Infectious Disease Indications. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, February 2010.
4. 4.↵
   1. Victoria J. G.,
   2. Wang C.,
   3. Jones M. S.,
   4. Jaing C.,
   5. McLoughlin K.,
   6. Gardner S.,
   7. Delwart E. L.

   Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus. J. Virol. 2010, 84 (12), 6033–6040.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Finsterbusch T.,
   2. Mankertz A.

   Porcine circoviruses—small but powerful. Virus Res. 2009, 143 (2), 177–183.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Li L.,
   2. Kapoor A.,
   3. Slikas B.,
   4. Bamidele O. S.,
   5. Wang C.,
   6. Shaukat S.,
   7. Masroor M. A.,
   8. Wilson M. L.,
   9. Ndjango J.-B. N.,
   10. Peeters M.,
   11. Gross-Camp N. D.,
   12. Muller M. N.,
   13. Hahn B. H.,
   14. Wolfe N. D.,
   15. Triki H.,
   16. Bartkus J.,
   17. Zaidi S. Z.,
   18. Delwart E.

   Multiple diverse circoviruses infect farm animals and are commonly found in human and chimpanzee feces. J. Virol. 2010, 84 (4), 1674–1682.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm212140.htm.
8. 8.↵
   1. Gillespie J.,
   2. Opriessnig T.,
   3. Meng X. J.,
   4. Pelzer K.,
   5. Buechner-Maxwell V.

   Porcine circovirus type 2 and porcine circovirus-associated disease. J. Vet. Intern. Med. 2009, 23 (6), 1151–1163.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Fenaux M.,
   2. Opriessnig T.,
   3. Halbur P. G.,
   4. Xu Y.,
   5. Potts B.,
   6. Meng X.-J.

   Detection and in vitro and in vivo characterization of porcine circovirus DNA from a porcine-derived commercial pepsin product. J. Gen. Virol. 2004, 85 (11), 3377–3382.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. McClenahan S.,
    2. Krause P. R.,
    3. Uhlenhaut C.

    Molecular and infectivity studies of porcine circovirus in vaccines. Vaccine 2011, 29 (29–30), 4745–4753.

    OpenUrlPubMed